The ‘innovation nation’ for supplements: Australian industry hails five-year protection for clinical trials
Industry leaders in Australia have hailed cross-party agreement that will lead to five years protection for clinical trials for complementary medicines and supplements, a world-first move that trade body Complementary Medicines Australia (CMA) says will reward companies at the cutting edge of research.